Concepedia

Publication | Open Access

A Pooled Analysis of Two Phase 3 Clinical Trials of Dalfampridine in Patients with Multiple Sclerosis

29

Citations

24

References

2014

Year

Abstract

D-ER demonstrated efficacy for the improvement of walking in patients with MS; response was independent of demographic and clinical characteristics.

References

YearCitations

Page 1